DUBLIN, May 17, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global In Vitro Fertilization (IVF) Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) Infertility is one of the major concerns in the world. One out of six couples in the world suffers from some form of infertility. About 10% women aged 20-44 suffer from infertility. There are various causes for infertility which include physiological (20-30% cases), some cases include genetically induced disorders whereas sometimes it may be self induced as in case of contraceptive surgeries. The market is driven by rising awareness amongst couples, a strong and developed health structure in developing nations, low cost treatment options available, and rise in the new methods like in vitro activation and surrogacy. The testing and treatment market is growing at a faster rate in males than females. The earlier social taboos among men regarding male fertility have been declining, leading to increase in the male infertility testing and treatment market. The cost of fertility treatment varies vastly from country to country leading to a rise in medial tourism in relationship with fertility treatments Israel is one of the leading countries with high quality treatments for infertility. The success rate of infertility treatment in Israel is around 46% which in one of the best globally . The companies profile in this report include:
Chap 2. Market overview 2.1. Market Share for Drug & Hormone Therapy 2.2. Key buying criteria 2.2.1. Treatment options 2.2.2. Quality of medical procedures 2.2.3. Price of treatments 2.2.4. Shift towards medical tourism 2.2.5. Reimbursement 2.3. Key Findings 2.3.1. highest growth in Male infertility treatment segment 2.3.2. Fertility tourism- The biggest growing trend 2.3.3. Upper middle income group is the key target 2.3.4. Regulatory environment key market enabler 2.3.5. Surrogacy preferred for failures in IVF treatments 2.3.6. Technological advancement enhancing success rates of fertility treatments
Chap 3. Male and Female Infertility 3.1. Causes 3.2. Ethical issues in infertility treatment
Chap 4. Market Determinants 4.1. Market Drivers 4.1.1. Rise in infertility 4.1.2. Fertility Tourism 4.1.3. Surrogacy also responsible for fertility tourism 4.1.4. Technological advancement in healthcare domain 4.1.5. Increase in success rate of treatments 4.1.6. Increasing acceptance of donor eggs by consumers 4.2. Market Restraints 4.2.1. Expensive procedure 4.2.2. Legal issues 4.3. Market Opportunities 4.3.1. Global requirement for low cost instruments and drugs in IVF 4.3.2. IVF an attractive sector for investment for private equity investors 4.3.3. Reproductive tourism 4.4. Market Challenges 4.4.1. Cost barrier for locals in emerging economies 4.4.2. Low acceptance of infertility treatment amongst men 4.4.3. Multiple births and birth defects
Chap 5. Market Segmentation 5.1. Male Infertility Market 5.2. Female infertility Chap 6. IVF & Infertility market geography wise
Chap 7. Company Profiling For more information visit http://www.researchandmarkets.com/research/b3nd6v/global_in_vitro
Media Contact: Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Advertisement
Research and Markets has announced the addition of the "Global In Vitro Fertilization (IVF) Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) Infertility is one of the major concerns in the world. One out of six couples in the world suffers from some form of infertility. About 10% women aged 20-44 suffer from infertility. There are various causes for infertility which include physiological (20-30% cases), some cases include genetically induced disorders whereas sometimes it may be self induced as in case of contraceptive surgeries. The market is driven by rising awareness amongst couples, a strong and developed health structure in developing nations, low cost treatment options available, and rise in the new methods like in vitro activation and surrogacy. The testing and treatment market is growing at a faster rate in males than females. The earlier social taboos among men regarding male fertility have been declining, leading to increase in the male infertility testing and treatment market. The cost of fertility treatment varies vastly from country to country leading to a rise in medial tourism in relationship with fertility treatments Israel is one of the leading countries with high quality treatments for infertility. The success rate of infertility treatment in Israel is around 46% which in one of the best globally . The companies profile in this report include:
Advertisement
- Andrology Solutions
- Auxilium Pharmaceuticals
- Auxogyn
- Ferring Pharmaceuticals
- Genea
- Halotech DNA
- Irvine Scientific
- Merck Serono
- Origio
- Ovascience
- Vitrolife AB
Chap 2. Market overview 2.1. Market Share for Drug & Hormone Therapy 2.2. Key buying criteria 2.2.1. Treatment options 2.2.2. Quality of medical procedures 2.2.3. Price of treatments 2.2.4. Shift towards medical tourism 2.2.5. Reimbursement 2.3. Key Findings 2.3.1. highest growth in Male infertility treatment segment 2.3.2. Fertility tourism- The biggest growing trend 2.3.3. Upper middle income group is the key target 2.3.4. Regulatory environment key market enabler 2.3.5. Surrogacy preferred for failures in IVF treatments 2.3.6. Technological advancement enhancing success rates of fertility treatments
Chap 3. Male and Female Infertility 3.1. Causes 3.2. Ethical issues in infertility treatment
Chap 4. Market Determinants 4.1. Market Drivers 4.1.1. Rise in infertility 4.1.2. Fertility Tourism 4.1.3. Surrogacy also responsible for fertility tourism 4.1.4. Technological advancement in healthcare domain 4.1.5. Increase in success rate of treatments 4.1.6. Increasing acceptance of donor eggs by consumers 4.2. Market Restraints 4.2.1. Expensive procedure 4.2.2. Legal issues 4.3. Market Opportunities 4.3.1. Global requirement for low cost instruments and drugs in IVF 4.3.2. IVF an attractive sector for investment for private equity investors 4.3.3. Reproductive tourism 4.4. Market Challenges 4.4.1. Cost barrier for locals in emerging economies 4.4.2. Low acceptance of infertility treatment amongst men 4.4.3. Multiple births and birth defects
Chap 5. Market Segmentation 5.1. Male Infertility Market 5.2. Female infertility Chap 6. IVF & Infertility market geography wise
Chap 7. Company Profiling For more information visit http://www.researchandmarkets.com/research/b3nd6v/global_in_vitro
Media Contact: Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
